DE SANCTIS, Francesco
 Distribuzione geografica
Continente #
EU - Europa 3.297
NA - Nord America 2.975
AS - Asia 2.166
SA - Sud America 320
AF - Africa 86
OC - Oceania 11
Continente sconosciuto - Info sul continente non disponibili 1
Totale 8.856
Nazione #
US - Stati Uniti d'America 2.901
RU - Federazione Russa 1.280
SG - Singapore 830
IT - Italia 621
CN - Cina 559
GB - Regno Unito 381
DE - Germania 266
VN - Vietnam 255
BR - Brasile 248
HK - Hong Kong 217
FI - Finlandia 152
IE - Irlanda 128
FR - Francia 126
SE - Svezia 121
KR - Corea 69
NL - Olanda 64
IN - India 48
ID - Indonesia 39
CA - Canada 37
UA - Ucraina 32
AT - Austria 27
TR - Turchia 27
AR - Argentina 25
BD - Bangladesh 25
JP - Giappone 25
ZA - Sudafrica 22
MX - Messico 21
BE - Belgio 18
PL - Polonia 17
TG - Togo 16
ES - Italia 15
IQ - Iraq 15
CO - Colombia 14
NG - Nigeria 13
SA - Arabia Saudita 12
BJ - Benin 10
PK - Pakistan 10
EC - Ecuador 9
PY - Paraguay 9
AU - Australia 8
CZ - Repubblica Ceca 8
VE - Venezuela 7
JM - Giamaica 6
KE - Kenya 6
LT - Lituania 6
TN - Tunisia 5
CL - Cile 4
EG - Egitto 4
HR - Croazia 4
IL - Israele 4
MA - Marocco 4
RS - Serbia 4
AL - Albania 3
AZ - Azerbaigian 3
CH - Svizzera 3
CR - Costa Rica 3
NZ - Nuova Zelanda 3
OM - Oman 3
PH - Filippine 3
PT - Portogallo 3
AE - Emirati Arabi Uniti 2
CY - Cipro 2
ET - Etiopia 2
IR - Iran 2
JO - Giordania 2
KG - Kirghizistan 2
MK - Macedonia 2
MY - Malesia 2
NO - Norvegia 2
SI - Slovenia 2
SK - Slovacchia (Repubblica Slovacca) 2
TW - Taiwan 2
AD - Andorra 1
AO - Angola 1
BA - Bosnia-Erzegovina 1
BG - Bulgaria 1
BO - Bolivia 1
BT - Bhutan 1
BW - Botswana 1
BY - Bielorussia 1
DK - Danimarca 1
GA - Gabon 1
GD - Grenada 1
GE - Georgia 1
GM - Gambi 1
GT - Guatemala 1
GY - Guiana 1
HN - Honduras 1
HU - Ungheria 1
IS - Islanda 1
LB - Libano 1
LU - Lussemburgo 1
MD - Moldavia 1
MO - Macao, regione amministrativa speciale della Cina 1
NI - Nicaragua 1
NP - Nepal 1
PA - Panama 1
PE - Perù 1
PS - Palestinian Territory 1
RO - Romania 1
Totale 8.850
Città #
Moscow 482
Ashburn 453
Singapore 418
Verona 339
San Jose 324
Southend 288
Chandler 247
Dallas 218
Hong Kong 209
Munich 168
Council Bluffs 137
Dublin 122
Beijing 119
New York 107
Helsinki 84
Jacksonville 84
The Dalles 79
Redmond 74
Los Angeles 69
Ho Chi Minh City 61
Houston 49
Woodbridge 48
Hanoi 43
Dong Ket 37
Jakarta 37
Wilmington 37
Lawrence 36
Princeton 36
Ann Arbor 33
Jinan 32
Santa Clara 30
Buffalo 29
São Paulo 29
London 26
Orem 26
Redondo Beach 26
Turku 26
Tokyo 24
Nanjing 22
Shenyang 22
Columbus 21
Lappeenranta 21
Milan 21
Denver 20
Amsterdam 18
Brussels 18
Frankfurt am Main 17
Montreal 17
Brooklyn 16
Johannesburg 16
Lomé 16
Atlanta 15
Chicago 15
Hebei 15
Phoenix 15
Redwood City 15
Sindelfingen 15
Warsaw 14
Washington 14
Zhengzhou 14
Guangzhou 13
Hangzhou 13
Toronto 13
Vienna 13
Abuja 12
Haikou 12
Nanchang 12
Seattle 12
Boston 11
Haiphong 11
Poplar 11
Stockholm 11
Tianjin 11
Boydton 10
Chennai 10
Cotonou 10
Jiaxing 10
Manchester 10
Nuremberg 10
Seoul 10
Belo Horizonte 9
Rome 9
New Delhi 8
Ningbo 8
Paris 8
Querétaro 8
St Louis 8
Taizhou 8
Boardman 7
Brasília 7
Falkenstein 7
Mexico City 7
Ankara 6
Baghdad 6
Barnet 6
Bogotá 6
Bologna 6
Changsha 6
Charlotte 6
Chions 6
Totale 5.430
Nome #
Immune checkpoint blockade therapy mitigates systemic inflammation and affects cellular FLIP-expressing monocytic myeloid-derived suppressor cells in non-progressor non-small cell lung cancer patients 312
MAP Kinase inhibition reshapes tumour microenvironment of mouse pancreatic cancer by depleting anti-inflammatory macrophages 303
Immunosuppression by monocytic myeloid-derived suppressor cells in patients with pancreatic ductal carcinoma is orchestrated by STAT3 267
Autologous cellular vaccine overcomes cancer immunoediting in a mouse model of myeloma 260
Deciphering the state of immune silence in fatal COVID-19 patients 240
Effective control of acute myeloid leukaemia and acute lymphoblastic leukaemia progression by telomerase specific adoptive T-cell therapy 224
Baricitinib restrains the immune dysregulation in patients with severe COVID-19 218
Feasibility of telomerase-specific adoptive T-cell therapy for B-cell chronic lymphocytic leukemia and solid malignancies 216
Hyperthermic treatment at 56 °C induces tumour-specific immune protection in a mouse model of prostate cancer in both prophylactic and therapeutic immunization regimens 212
Immunoevolution of mouse pancreatic organoid isografts from preinvasive to metastatic disease 209
Disabled homolog 2 controls pro-metastatic activity of tumor-associated macrophages 209
Fatal cytokine release syndrome by an aberrant FLIP/STAT3 axis 198
Induction of immunosuppressive functions and NF-κB by FLIP in monocytes 195
Dynamics of SARS-CoV2 Infection and Multi-Drug Resistant Bacteria Superinfection in Patients With Assisted Mechanical Ventilation 195
Axon guidance cue SEMA3A promotes the aggressive phenotype of basal-like PDAC 190
Antibody-based delivery of interleukin-2 modulates the immunosuppressive tumor microenvironment and achieves cure in pancreatic ductal adenocarcinoma syngeneic mice 188
Organoid-Transplant Model Systems to Study the Effects of Obesity on the Pancreatic Carcinogenesis in vivo 179
The Emerging Immunological Role of Post-Translational Modifications by Reactive Nitrogen Species in Cancer Microenvironment 176
The immune modulatory effects of umbilical cord-derived mesenchymal stromal cells in severe COVID-19 pneumonia 173
Interrupting the nitrosative stress fuels tumor-specific cytotoxic T lymphocytes in pancreatic cancer 171
MDSCs in cancer: Conceiving new prognostic and therapeutic targets 168
Neutralization of NET-associated human ARG1 enhances cancer immunotherapy 166
The Endless Saga of Monocyte Diversity 165
Anti-telomerase T cells adoptive transfer 165
Local ablation disrupts immune evasion in pancreatic cancer 158
Neutrophils inhibit γδ T cell functions in the imiquimod-induced mouse model of psoriasis 156
Intratumoral injection of TLR9 agonist promotes an immunopermissive microenvironment transition and causes cooperative antitumor activity in combination with anti-PD1 in pancreatic cancer 156
Expression of the membrane tetraspanin claudin 18 on cancer cells promotes T lymphocyte infiltration and antitumor immunity in pancreatic cancer 155
A Tumor Mitochondria Vaccine Protects against Experimental Renal Cell Carcinoma 152
The Engagement Between MDSCs and Metastases: Partners in Crime 147
Breaking the Immune Complexity of the Tumor Microenvironment Using Single-Cell Technologies 146
Cellular collusion: cracking the code of immunosuppression and chemo resistance in PDAC 142
Tumor-induced myeloid deviation: when myeloid-derived suppressor cells meet tumor-associated macrophages 136
Tumor endothelial marker 1-specific DNA vaccination targets tumor vasculature 136
Arginase 1-Based Immune Modulatory Vaccines Induce Anticancer Immunity and Synergize with Anti-PD-1 Checkpoint Blockade. 133
CXCR1/2 dual-inhibitor ladarixin reduces tumour burden and promotes immunotherapy response in pancreatic cancer 132
Methods to Measure MDSC Immune Suppressive Activity In Vitro and In Vivo 130
Targeting tumor vasculature: expanding the potential of DNA cancer vaccines 129
T-cell tracking using Cerenkov and radioluminescence imaging 129
"Open Sesame" to the complexity of pattern recognition receptors of myeloid-derived suppressor cells in cancer 126
Colorectal cancer patients-derived immunity-organoid platform unveils cancer-specific tissue markers associated with immunotherapy resistance 123
A Complex Metabolic Network Confers Immunosuppressive Functions to Myeloid-Derived Suppressor Cells (MDSCs) within the Tumour Microenvironment 114
Four-class tumor staging for early diagnosis and monitoring of murine pancreatic cancer using magnetic resonance and ultrasound 112
Overview of the optical properties of fluorescent nanoparticles for optical imaging 111
Tumor-Induced Myeloid-Derived Suppressor Cells 109
The dark side of tumor-associated endothelial cells 107
Tandem Dye-Doped Nanoparticles for NIR Imaging via Cerenkov Resonance Energy Transfer 106
Local endothelial complement activation reverses endothelial quiescence, enabling t-cell homing, and tumor control during t-cell immunotherapy 103
Monocytes in the Tumor Microenvironment 100
Targeting tumour-reprogrammed myeloid cells: the new battleground in cancer immunotherapy 96
Optical emission of (223) Radium: in vitro and in vivo preclinical applications 96
p140Cap inhibits β-Catenin in the breast cancer stem cell compartment instructing a protective anti-tumor immune response 94
Talniflumate abrogates mucin immune suppressive barrier improving efficacy of gemcitabine and nab-paclitaxel treatment in pancreatic cancer 87
Targeting Inhibition of Accumulation and Function of Myeloid-Derived Suppressor Cells by Artemisinin via PI3K/AKT, mTOR, and MAPK Pathways Enhances Anti-PD-L1 Immunotherapy in Melanoma and Liver Tumors 82
Harnessing the reverse cholesterol transport pathway to favor differentiation of monocyte-derived APCs and antitumor responses 71
How to Reprogram Myeloma-Associated Macrophages: Target {IKZF}1 59
Maternal Phylogenetic Relationships and Genetic Variation among Rare, Phenotypically Similar Donkey Breeds 56
IL-27: overclocking cytotoxic T lymphocytes to boost cancer immunotherapy 48
A comprehensive longitudinal analysis of the cellular immune response specific to the spike protein in healthcare workers vaccinated against SARS-CoV-2- ORCHESTRA Project 43
Pluripotent stem-cell-based screening uncovers sildenafil as a mitochondrial disease therapy 20
c-FLIP as a master regulator of immune homeostasis and disease mechanisms 10
Transcriptional and Epigenetic Plasticity Drive an Alternative Non-clonal Mechanism of Resistance to Kras G12D Inhibition in Pancreatic Cancer 5
Totale 9.014
Categoria #
all - tutte 30.868
article - articoli 29.973
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 895
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 61.736


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/202181 0 0 0 0 0 0 0 0 0 0 0 81
2021/2022330 20 82 34 21 10 5 14 29 19 8 19 69
2022/2023752 44 89 62 136 59 193 13 35 75 5 30 11
2023/2024585 20 35 44 54 65 117 51 32 4 46 89 28
2024/20251.732 79 59 83 243 61 86 208 155 238 86 153 281
2025/20264.383 280 226 279 700 1.120 276 404 234 375 295 88 106
Totale 9.014